Wogonin supplementation is believed to reduce cytokines such as IL‐6 and TNF‐ and reduce PPAR‐mediated phosphorylation that subsequently decreases the viability of RAW264.7 cells in liver cancer conditions. Here, IL6 is linked to liver cancer.